Alberta-based Aurora Cannabis stated it acquired the inexperienced mild to ship medical hashish to Poland, making the Canadian firm “the first nongovernment-run business” to win approval to provide medical marijuana merchandise within the japanese European nation.
Aurora Deutschland GmbH – Aurora’s German subsidiary – will ship the merchandise to a ache remedy middle and a hospital in Warsaw within the coming days, the corporate introduced in a information launch.
Since legalizing medical hashish in 2017, the Polish medical hashish market has suffered from a scarcity of provide. That’s as a result of the supporting laws bans cultivation inside Poland.
Under the laws, physicians are capable of prescribe medical hashish merchandise to sufferers, who can then entry it by means of pharmacies.
In some situations, merchandise may be coated underneath Poland’s statutory medical insurance.
Treatable circumstances embrace chemotherapy-induced nausea, a number of sclerosis, persistent ache and epilepsy.
In a regulatory submitting in September, Aurora stated it’s the European Union’s largest distributor of medical hashish.
Aurora, which employs greater than 70 individuals in Europe, just lately established a pan-European firm, Aurora Europe GmbH, headquartered in Berlin. Other subsidiaries within the European Union embrace Aurora Italia, Aurora Malta and Aurora Nordic (Denmark).
Aurora didn’t instantly reply to queries from Marijuana Business Daily.
Aurora’s shares are traded on the New York Stock Exchange as ACB and on the Toronto Stock Exchange as ACB.
To join our weekly worldwide marijuana enterprise publication, click on right here.